Intrinsic Value of S&P & Nasdaq Contact Us

EQRx, Inc. EQRX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+113.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

EQRx, Inc. (EQRX) trades at a trailing P/E of 5.4. Trailing earnings yield is 18.38%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — P/E is below market average (5.4); analyst target implies upside (+113.7%); earnings yield beats bond yields (18.38%).
  • Trailing Earnings Yield 18.38% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
  • Analyst consensus target $5.00 (+113.7% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 48/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
50/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
40/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — EQRX

Valuation Multiples
P/E (TTM)5.4
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.43
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings Yield18.38%
Dividend Yield0.00%
Analyst Target$5.00 (+113.7%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-5.99 $0.00 $-25.52K -
2020 $-0.80 $0.00 $-249.89M -
2021 $-0.28 $0.00 $-90.69M -
2022 $0.43 $0.00 $205.49M -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message